EMA shortages Shortage resolved Medicine shortages
Zirabev — supply shortage (shortage resolved)
Published by European Medicines Agency:
Summary
Supply shortage
Medicine
Zirabev
- Category
- Medicine shortages
- Product type
- Human medicine
- Active substance (INN): bevacizumab
- Therapeutic area: Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms
- Pharmaceutical forms affected: Concentrate for solution for infusion
- Strengths affected: 100mg/4ml ;400mg/16ml
- Last updated: 10/04/2025
Source: EMA — medicine shortages — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗